Literature DB >> 15110800

The GRIMs: a new interface between cell death regulation and interferon/retinoid induced growth suppression.

Dhananjaya V Kalvakolanu1.   

Abstract

Cytokines and vitamins play a central role in controlling neoplastic cell growth. The interferon (IFN) family of cytokines regulates antiviral, anti-tumor, antimicrobial, differentiation, and immune responses in mammals. Significant advances have been made with respect to IFN-induced signal transduction pathways and antiviral responses. However, the IFN-induced anti-tumor actions are poorly defined. Although IFNs themselves inhibit tumor growth, combination of IFNs with retinoids (a class of Vitamin A related compounds) strongly potentiates the IFN-regulated anti-tumor action in a number of cell types. To define the molecular mechanisms involved in IFN/retinoid (RA)-induced apoptosis we have employed a genetic approach and identified several critical genes. In this review, I provide the current picture of IFN- RA- and IFN/RA-regulated growth suppressive pathways. In particular, I focus on a novel set of genes, the genes-associated with retinoid-interferon induced mortality (GRIM). GRIMs may be novel types of tumor suppressors, useful as biological response markers and potentially novel targets for drug development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15110800     DOI: 10.1016/j.cytogfr.2004.01.002

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  29 in total

1.  GRIM-19 is essential for maintenance of mitochondrial membrane potential.

Authors:  Hao Lu; Xinmin Cao
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

Review 2.  The interferon signaling network and transcription factor C/EBP-beta.

Authors:  Hui Li; Padmaja Gade; Weihua Xiao; Dhan V Kalvakolanu
Journal:  Cell Mol Immunol       Date:  2007-12       Impact factor: 11.530

3.  Regulation of apoptosis by type III interferons.

Authors:  W Li; A Lewis-Antes; J Huang; M Balan; S V Kotenko
Journal:  Cell Prolif       Date:  2008-12       Impact factor: 6.831

Review 4.  Aging and the immune system.

Authors:  Reginald M Gorczynski; Ender Terzioglu
Journal:  Int Urol Nephrol       Date:  2008-08-06       Impact factor: 2.370

Review 5.  Viral subversion of apoptotic enzymes: escape from death row.

Authors:  Sonja M Best
Journal:  Annu Rev Microbiol       Date:  2008       Impact factor: 15.500

6.  GRIM-19 and p16(INK4a) synergistically regulate cell cycle progression and E2F1-responsive gene expression.

Authors:  Peng Sun; Shreeram C Nallar; Abhijit Raha; Sudhakar Kalakonda; Chidambaram N Velalar; Sekhar P Reddy; Dhananjaya V Kalvakolanu
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

7.  Identification of a structural motif in the tumor-suppressive protein GRIM-19 required for its antitumor activity.

Authors:  Shreeram C Nallar; Sudhakar Kalakonda; Peng Sun; Yoshihiro Ohmori; Miki Hiroi; Kazumasa Mori; Daniel J Lindner; Dhananjaya V Kalvakolanu
Journal:  Am J Pathol       Date:  2010-07-01       Impact factor: 4.307

Review 8.  Cytokine-induced tumor suppressors: a GRIM story.

Authors:  Dhan V Kalvakolanu; Shreeram C Nallar; Sudhakar Kalakonda
Journal:  Cytokine       Date:  2010-04-10       Impact factor: 3.861

9.  Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.

Authors:  Shreeram C Nallar; Sudhakar Kalakonda; Daniel J Lindner; Robert R Lorenz; Eric Lamarre; Xiao Weihua; Dhananjaya V Kalvakolanu
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

10.  Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.

Authors:  Sudhakar Kalakonda; Shreeram C Nallar; Ping Gong; Daniel J Lindner; Simeon E Goldblum; Sekhar P Reddy; Dhananjaya V Kalvakolanu
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.